NISHIYAMA Hiroyuki

Researcher's full information

Articles

• Combined Molecular Subclass and Immune Phenotype Correlate to Atezolizumab Plus Radiation Therapy Response in Invasive Bladder Cancer: BPT-ART Phase 2 Study
  Nagumo Yoshiyuki; Hattori Kyosuke; Kimura Tomokazu; Se...
  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS/122(1)/pp.168-180, 2025-05-01
• Avelumab maintenance therapy in patients (pts) with advanced urothelial carcinoma (UC) in Japan: Subgroup analyses by prior chemotherapy regimen from post-marketing surveillance (PMS).
  Nagata Masayoshi; Kikuchi Eiji; Ito Taito; Sato Masas...
  JOURNAL OF CLINICAL ONCOLOGY/43(5_SUPPL:5_SUPPL), 2025-02-10
• A case of cerebral infarction caused by carbon dioxide embolism during robotic-assisted laparoscopic partial nephrectomy
  Shiga Miho; Shiga Masanobu; Isoda Bunpei; Nitta Satos...
  UROLOGY CASE REPORTS/60, 2025-05
• A Case of Secondary Extramammary Paget's Disease Surrounding a Cutaneous Ureterostoma After Recurrence of Bladder Urothelial Carcinoma
  Mizoguchi Masahiro; Chihara Ichiro; Sano Keisuke; Kimu...
  IJU CASE REPORTS, 2025-03-27
• A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA)
  Powles T. B.; van der Heijden M. S.; Galsky M. D.; Al-...
  ANNALS OF ONCOLOGY/35(2)/pp.1271-1271, 2024-09
• JCOG1019: An open-label, non-inferiority, randomised phase III study comparing the effectiveness of watchful waiting (WW) and intravesical Bacillus Calmette-Guerin (BCG) in patients (Pts) with high-grade pT1 (HGT1) bladder cancer with pT0 on the second transurethral resection (TUR) specimen
  Kitamura H.; Mizusawa J.; Shibata T.; Sasaki K.; Hash...
  ANNALS OF ONCOLOGY/35(2)/pp.S1134-S1135, 2024-09
• Nomogram predicting the outcome of salvage radiation therapy for prostate-specific antigen failure following radical prostatectomy: an exploratory analysis of a randomized, multicenter, open-label, phase 3 trial (JCOG0401)
  Tohi Yoichiro; Yokomizo Akira; Kimura Takahiro; Wakaba...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025-03-08
• Primary analysis of post-marketing surveillance (PMS) data for avelumab maintenance therapy in patients (pts) with curatively unresectable urothelial carcinoma (UC) in Japan
  Kikuchi E.; Nagata M.; Ito T.; Sato M.; Ogi M.; Mori...
  ANNALS OF ONCOLOGY/35(2)/pp.S1155-S1155, 2024-09
• Long term survival in elderly patients with resectable upper tract urothelial carcinoma: analysis of hospital-based cancer registry data in Japan
  Suzuki Shuhei; Nagumo Yoshiyuki; Kojo Kosuke; Kandori ...
  BMC CANCER/25(1), 2025-03-13
• Antitumor effects and mechanisms of ethylene glycol derivatives of squalene in bladder cancer
  Sano Keisuke; Shiga Masanobu; Tanuma Kouzaburou; Kando...
  CANCER SCIENCE/116(1:SI)/pp.592-592, 2025-01
• Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy
  Hara Shuhei; Fukuokaya Wataru; Miki Jun; Taoka Rikiya...
  INTERNATIONAL JOURNAL OF UROLOGY/Epub, 2025-02-05
• Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
  Powles Thomas; Catto James W. F.; Galsky Matthew D.; A...
  NEW ENGLAND JOURNAL OF MEDICINE/391(19)/pp.1773-1786, 2024-11-14
• Impact of lymph node dissection during surgery on the efficacy of pembrolizumab in patients with metastatic urothelial carcinoma
  Kanno Toru; Ito Katsuhiro; Kita Yuki; Mochizuki Takan...
  INTERNATIONAL JOURNAL OF UROLOGY/Epub, 2025-02-10
• Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatment
  Ohba Kojiro; Osawa Takahiro; Kojima Takahiro; Hara To...
  INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/Epub, 2025-02-14
• Avelumab maintenance therapy in older patients with advanced urothelial carcinoma in Japan: Subgroup analyses of data from post-marketing surveillance by age group
  Nagata M.; Kikuchi E.; Ito T.; Sato M.; Morita M.; K...
  ANNALS OF ONCOLOGY/35(4)/pp.S1512-S1512, 2024-12
• Surgery lengthens survival for collecting duct carcinoma: analysis of hospital-based cancer registry data in Japan
  Kandori Shuya; Suzuki Shuhei; Kojo Kosuke; Isoda Bunp...
  BMC CANCER/25(1), 2025-01-24
• Feasibility of enzalutamide on patients with recurrent non-muscle-invasive bladder cancer with marker tumors: phase I study
  Kawahara Takashi; Kandori Shuya; Kojima Takahiro; Math...
  BMC RESEARCH NOTES/18(1), 2025-01-31
• Tumor suppressive effect of intraperitoneal administration of Trehalose 6,6'-dimycolate liposomes
  Tanuma Kozaburo; Shiga Masanobu; Kandori Shuya; Miyaza...
  CANCER SCIENCE/115(1)/pp.569-569, 2024-03
• Elucidation of the progression mechanism in renal cell carcinoma via ELOVL5
  Nitta Satoshi; Kandori Shuya; Sakka Shotaro; Nishiyama...
  CANCER SCIENCE/115(1)/pp.100-100, 2024-03
• ELOVL2/ELOVL5 as promoters of renal cancer progression through cellular movement regulation
  Sakka Shotaro; Kandori Shuya; Nitta Satoshi; Nagumo Y...
  CANCER SCIENCE/115(1)/pp.1410-1410, 2024-03
• This Issue 32-3
  Nishiyama Hiroyuki
  INTERNATIONAL JOURNAL OF UROLOGY/Epub, 2025-02-14
• Impact of aspirin on biochemical recurrence of prostate cancer after robot assisted radical prostatectomy in a multicenter retrospective cohort study
  Suzuki Shuhei; Negoro Hiromitsu; Kubota Masashi; Sumiy...
  SCIENTIFIC REPORTS/15(1), 2025-01-15
• STUDY DESIGN, PROTOCOL, AND HUMAN HEALTH EFFECTS OF PFAS IN THE TSUKUBA CITY COHORT
  Eun Heesoo; Yoon Jieun; Kameyama Mayumi; Hata Hiroshi...
  INNOVATION IN AGING/8(1:SI)/pp.1277-1277, 2024-12-31
• The correlation between discrepancies in clinical and pathological T stages and overall survival in upper urinary tract urothelial carcinoma: Analysis of the hospital-based cancer registry data in Japan
  Shiga Masanobu; Nagumo Yoshiyuki; Kojo Kosuke; Kandori...
  INTERNATIONAL JOURNAL OF UROLOGY/Epub, 2025-01-03
• “Nephron mass” 定量から予測する生体腎移植術後腎機能─CT vs 病理
  高橋　一広; 古屋　欽司; 中橋 宏充; 臼井　丈一; 中島　健太郎; 新田　聡; 星　昭夫; 西山　博之; 小...
  日本臨床腎移植学会雑誌/12(2)/pp.201-208, 2024-12
• more...